معرفی
David Baylink is a Distinguished Professor at Loma Linda University, holding appointments in the School of Medicine and School of Dentistry. He serves as Head of the Regenerative Medicine Division within the Department of Medicine. His interdisciplinary roles reflect his broad impact across medicine, basic sciences, and dental education.
- Doctor of Medicine, Loma Linda University, 1957
- Bachelor of Arts, Walla Walla University, 1953
Dr. Baylink's research is centered on regenerative medicine, molecular biology, and bone metabolism. His work explores stem cell reprogramming, gene therapy, vitamin D signaling, and the molecular mechanisms underlying skeletal diseases. He has pioneered methods for generating integration-free iPSCs and reprogramming blood cells into stem cell lineages using minimal factors. His investigations into nutrient-gene interactions and the tumor microenvironment have extended into cancer immunotherapy and metabolic targeting in leukemia and pancreatic cancer.
The recent publications (2024–2025) reveal a strong focus on innovative therapeutic strategies, including nutrient-gene therapy for CAR T cells, targeting the Warburg effect in AML, and exploiting NFκB2 signaling in drug-resistant cancers. Earlier works emphasize regenerative approaches using vitamin D metabolism, Wnt signaling, and oxidative stress in stem cell function. Collectively, these articles span oncology, immunology, molecular biology, and regenerative medicine, demonstrating a sustained and evolving research program.
Although no specific scientific awards are listed in the provided text, Dr. Baylink’s designation as a Distinguished Professor and his extensive publication and project history imply significant recognition in his fields.
Dr. Baylink has been actively involved in numerous research projects, often as a Co-Investigator, focusing on gene therapy, stem cell reprogramming, and metabolic interventions. While formal student advising is not explicitly mentioned, his leadership in research suggests mentorship of junior scientists. He collaborates extensively with researchers such as K.-H. William Lau, Jianfeng Xu, Xiao-Bing Zhang, and Hemant Kumar.
His work is conducted within the research infrastructure of Loma Linda University, particularly in the Regenerative Medicine Division and associated laboratories focused on molecular and cellular therapies. These teams emphasize translational approaches bridging basic science and clinical applications.
